| Item Type | Name |
|
Concept
|
Etoposide
|
|
Academic Article
|
Multidrug resistance in a small cell lung cancer line: rapid selection with etoposide and differential chemosensitization with cyclosporin A.
|
|
Academic Article
|
Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
|
|
Academic Article
|
Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancer.
|
|
Academic Article
|
A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.
|
|
Academic Article
|
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.
|
|
Academic Article
|
Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer.
|
|
Academic Article
|
Etoposide-induced DNA cleavage in human leukemia cells.
|
|
Academic Article
|
Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity.
|
|
Academic Article
|
Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells.
|
|
Academic Article
|
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer.
|
|
Academic Article
|
Enhanced expression of HLA-A,B,C and inducibility of TAP-1, TAP-2, and HLA-A,B,C by interferon-gamma in a multidrug-resistant small cell lung cancer line.
|
|
Academic Article
|
Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
|
|
Academic Article
|
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
|
|
Academic Article
|
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12.
|
|
Academic Article
|
Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?
|
|
Academic Article
|
Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
|
|
Academic Article
|
Primary chemotherapy of brain metastasis in small-cell lung cancer.
|
|
Academic Article
|
Role of proliferation in determining sensitivity to topoisomerase II-active chemotherapy agents.
|
|
Academic Article
|
Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents.
|
|
Academic Article
|
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
|
|
Academic Article
|
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
|
|
Academic Article
|
A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer.
|
|
Academic Article
|
Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids.
|
|
Academic Article
|
Resectability of small-cell lung cancer following induction chemotherapy in patients with limited disease (stage II-IIIb).
|
|
Academic Article
|
Mediation of multi-drug resistance in a Chinese hamster ovary cell line by a mutant type II topoisomerase.
|
|
Academic Article
|
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.
|
|
Academic Article
|
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
|
|
Academic Article
|
Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma.
|
|
Academic Article
|
Proliferation dependence of topoisomerase II mediated drug action.
|
|
Academic Article
|
Integration of filgrastim into chemoradiation for limited small cell lung cancer: a Phase I study.
|
|
Academic Article
|
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.
|
|
Academic Article
|
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer.
|
|
Academic Article
|
Outcomes for olfactory neuroblastoma treated with induction chemotherapy.
|
|
Academic Article
|
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma.
|